Your browser doesn't support javascript.
loading
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study.
Gerds, Aaron T; Verstovsek, Srdan; Vannucchi, Alessandro M; Al-Ali, Haifa Kathrin; Lavie, David; Kuykendall, Andrew T; Grosicki, Sebastian; Iurlo, Alessandra; Goh, Yeow Tee; Lazaroiu, Mihaela C; Egyed, Miklos; Fox, Maria Laura; McLornan, Donal; Perkins, Andrew; Yoon, Sung-Soo; Gupta, Vikas; Kiladjian, Jean-Jacques; Granacher, Nikki; Lee, Sung-Eun; Ocroteala, Luminita; Passamonti, Francesco; Harrison, Claire N; Oh, Stephen; Klencke, Barbara J; Yu, Jing; Donahue, Rafe; Kawashima, Jun; Mesa, Ruben.
Afiliação
  • Gerds AT; Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA. Electronic address: gerdsa@ccf.org.
  • Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vannucchi AM; Department of Hematology, University of Florence, Florence, Italy; Center of Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Florence, Italy.
  • Al-Ali HK; Krukenberg Cancer Center, University Hospital of Halle, Halle, Germany.
  • Lavie D; Department of Hematology and Bone Marrow Transplantation, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Kuykendall AT; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA.
  • Grosicki S; Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland.
  • Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Goh YT; Department of Haematology, Singapore General Hospital, Singapore.
  • Lazaroiu MC; Department of Hematology, Policlinica de Diagnostic Rapid Brasov, Brasov, Romania.
  • Egyed M; Department of Hematology, Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary.
  • Fox ML; Department of Haematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • McLornan D; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Perkins A; Department of Haematology, Alfred Hospital, Monash University, Melbourne, VIC, Australia.
  • Yoon SS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Gupta V; Department of Medicine, Princess Margaret Cancer Centre, Toronto, ON, Canada.
  • Kiladjian JJ; Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Paris, France.
  • Granacher N; Department of Hematology, Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium.
  • Lee SE; Department of Hematology, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Ocroteala L; Department of Hematology, Filantropia Hospital, Craiova, Romania.
  • Passamonti F; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  • Harrison CN; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Oh S; Division of Hematology, Washington University School of Medicine, St Louis, MO, USA.
  • Klencke BJ; Sierra Oncology, San Mateo, CA, USA.
  • Yu J; GSK, Philadelphia, PA, USA.
  • Donahue R; Sierra Oncology, San Mateo, CA, USA.
  • Kawashima J; Sierra Oncology, San Mateo, CA, USA.
  • Mesa R; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Lancet Haematol ; 10(9): e735-e746, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37517413

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases / Anemia Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mielofibrose Primária / Inibidores de Janus Quinases / Anemia Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies Limite: Adolescent / Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article